Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 569687-82-7 | MDL No. : | MFCD02181061 |
Formula : | C11H14N2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SEMXBDMLULHKBL-UHFFFAOYSA-N |
M.W : | 238.24 | Pubchem ID : | 1502052 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.36 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 61.44 |
TPSA : | 88.52 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.45 cm/s |
Log Po/w (iLOGP) : | 1.76 |
Log Po/w (XLOGP3) : | 1.83 |
Log Po/w (WLOGP) : | 1.94 |
Log Po/w (MLOGP) : | -0.63 |
Log Po/w (SILICOS-IT) : | 0.61 |
Consensus Log Po/w : | 1.1 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.4 |
Solubility : | 0.946 mg/ml ; 0.00397 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.31 |
Solubility : | 0.117 mg/ml ; 0.000491 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.36 |
Solubility : | 1.05 mg/ml ; 0.0044 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.41 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 848308-47-4 ]
5-((tert-Butoxycarbonyl)amino)picolinic acid
Similarity: 0.82
[ 56700-70-0 ]
tert-Butyl pyridin-3-ylcarbamate
Similarity: 0.75
[ 171178-34-0 ]
4-((tert-Butoxycarbonyl)amino)nicotinic acid
Similarity: 0.74
[ 337904-92-4 ]
5-((tert-Butoxycarbonyl)amino)nicotinic acid
Similarity: 0.74
[ 116026-95-0 ]
tert-Butyl (4-formylpyridin-3-yl)carbamate
Similarity: 0.72
[ 848308-47-4 ]
5-((tert-Butoxycarbonyl)amino)picolinic acid
Similarity: 0.82
[ 56700-70-0 ]
tert-Butyl pyridin-3-ylcarbamate
Similarity: 0.75
[ 171178-34-0 ]
4-((tert-Butoxycarbonyl)amino)nicotinic acid
Similarity: 0.74
[ 337904-92-4 ]
5-((tert-Butoxycarbonyl)amino)nicotinic acid
Similarity: 0.74
[ 116026-95-0 ]
tert-Butyl (4-formylpyridin-3-yl)carbamate
Similarity: 0.72
[ 848308-47-4 ]
5-((tert-Butoxycarbonyl)amino)picolinic acid
Similarity: 0.82
[ 171178-34-0 ]
4-((tert-Butoxycarbonyl)amino)nicotinic acid
Similarity: 0.74
[ 337904-92-4 ]
5-((tert-Butoxycarbonyl)amino)nicotinic acid
Similarity: 0.74
[ 945840-82-4 ]
1H-Pyrrolo[2,3-c]pyridine-7-carboxylic acid
Similarity: 0.71
[ 848308-47-4 ]
5-((tert-Butoxycarbonyl)amino)picolinic acid
Similarity: 0.82
[ 56700-70-0 ]
tert-Butyl pyridin-3-ylcarbamate
Similarity: 0.75
[ 171178-34-0 ]
4-((tert-Butoxycarbonyl)amino)nicotinic acid
Similarity: 0.74
[ 337904-92-4 ]
5-((tert-Butoxycarbonyl)amino)nicotinic acid
Similarity: 0.74
[ 116026-95-0 ]
tert-Butyl (4-formylpyridin-3-yl)carbamate
Similarity: 0.72